Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    6610841 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
Conditions: Alzheimer's Disease (AD);   Parkinson's Disease (PD);   Chronic Traumatic Encephalopathy (CTE);   Progressive Supranuclear Palsy (PSP);   Frontal Temporal Dementia (FTD);   Pick's Disease;   Tauopathies
Intervention: Drug: [18F]T807 ([18F]MNI-777)
2 Active, not recruiting 18-Month Study of Curcumin
Conditions: Age-associated Cognitive Impairment;   Mild Cognitive Impairment (MCI)
Interventions: Drug: Curcumin;   Other: Placebo
3 Recruiting Blood Brain Barrier Opening in Alzheimer' Disease
Condition: Alzheimer Disease
Intervention: Device: SONOCLOUD®
4 Completed A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Nilvadipine;   Drug: Placebo
5 Completed Web-based Psycho-Educational Program to Support Carers of Alzheimer's Patients
Conditions: Caregivers;   Alzheimer Disease,;   Psycho-educational Web-based Program,;   Stress,;   Self-efficacy,;   Burden.
Interventions: Behavioral: psycho-social intervention based on a web-based psycho-educational program, called Diapason.;   Behavioral: Consultation in memory clinic
6 Completed Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain
Condition: Alzheimer Disease
Intervention: Drug: [123I] IMPY & SPECT Imaging

Study has passed its completion date and status has not been verified in more than two years.